Specifically, TXLNA was linked to hepatitis B (Supplementary Figure S5C), SVMRS to hepatitis C (Supplementary Figure S5D), and RAET1E to non-alcoholic fatty liver disease (Supplementary Figure S5E). Here, TXLNA is linked to metabolic dysfunction-associated steatotic liver disease.